Home › Funds › Vivo Capital, LLC › ANRO

Vivo Capital, LLC position in ANRO

ALTO NEUROSCIENCE INC · Health Care

Vivo Capital, LLC reported holding 1,359,915 shares of ANRO (ALTO NEUROSCIENCE INC) in its Q3 2026 13F filing — a position valued at US$34.7M, representing 3.94% of its reported portfolio and ranking #8 among its reported holdings. Vivo Capital, LLC has disclosed ANRO holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)1.36M sh
Reported value held$34.72M
Portfolio Weight3.94%
First reportedQ4 2025
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Vivo Capital, LLC's ANRO position evolved

Vivo Capital, LLC first disclosed a stake in ANRO in Q4 2025 at 1,035,551 shares (US$18.4M). The position peaked in Q3 2026 at 1,359,915 shares, worth US$34.7M. Across 4 filings, Vivo Capital, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,359,915 shares valued at US$34.7M — an increase of 151,057 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 1.04M $18.43M New
Q1 2026 1.04M $23.28M Hold
Q2 2026 1.21M $31.90M Add
Q3 2026 1.36M $34.72M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ANRO and 13F data

ANRO (ALTO NEUROSCIENCE INC) is a Health Care company. 61 other funds we track also report a position in ANRO — the largest reported positions include Alpha Wave Global, LP (US$97.8M), Commodore Capital LP (US$71.9M), PERCEPTIVE ADVISORS LLC (US$42.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ANRO

All ANRO fund holders →

FAQ

How long has Vivo Capital, LLC held ANRO?

Vivo Capital, LLC has disclosed ANRO holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Vivo Capital, LLC's current position in ANRO?

As of Q3 2026, Vivo Capital, LLC holds 1.36M shares of ANRO (ALTO NEUROSCIENCE INC), valued at $34.72M, representing 3.94% of its reported portfolio and ranking #8.

Has Vivo Capital, LLC been buying or selling ANRO?

In the latest 13F filing (Q3 2026), Vivo Capital, LLC increased its position in ANRO. The position peaked in Q3 2026 at 1.36M shares.

Which other funds hold ANRO?

Other major institutional holders of ANRO include Alpha Wave Global, LP, Commodore Capital LP, PERCEPTIVE ADVISORS LLC, among 61 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.